Itsuhiro Takizawa

482 total citations
26 papers, 334 citations indexed

About

Itsuhiro Takizawa is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Itsuhiro Takizawa has authored 26 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 14 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Genetics. Recurrent topics in Itsuhiro Takizawa's work include Prostate Cancer Treatment and Research (19 papers), Hormonal and reproductive studies (10 papers) and Estrogen and related hormone effects (6 papers). Itsuhiro Takizawa is often cited by papers focused on Prostate Cancer Treatment and Research (19 papers), Hormonal and reproductive studies (10 papers) and Estrogen and related hormone effects (6 papers). Itsuhiro Takizawa collaborates with scholars based in Japan, Australia and Sweden. Itsuhiro Takizawa's co-authors include Noboru Hara, Tsutomu Nishiyama, Kota Takahashi, Yoshimichi Miyashiro, Yasuo Kitamura, Toshihiro Saito, Takashi Kawasaki, Makoto Naito, Makoto Kawaguchi and Kei Arai and has published in prestigious journals such as Scientific Reports, The Journal of Urology and Cancer Letters.

In The Last Decade

Itsuhiro Takizawa

25 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Itsuhiro Takizawa Japan	11	214	102	68	59	49	26	334
Nadia Ben Lagha France	8	80 0.4×	40 0.4×	119 1.8×	54 0.9×	28 0.6×	16	272
Maddalena Grosso Italy	11	105 0.5×	33 0.3×	94 1.4×	38 0.6×	16 0.3×	31	315
P Y Chong Singapore	9	86 0.4×	34 0.3×	125 1.8×	65 1.1×	22 0.4×	14	331
Giancarlo Comeri Italy	10	371 1.7×	159 1.6×	54 0.8×	65 1.1×	45 0.9×	17	502
D. Potenzoni Italy	10	192 0.9×	58 0.6×	46 0.7×	39 0.7×	41 0.8×	21	341
Anthony Rizzo United States	8	53 0.2×	35 0.3×	96 1.4×	30 0.5×	44 0.9×	15	389
Sandy Azoulay France	8	147 0.7×	23 0.2×	147 2.2×	97 1.6×	26 0.5×	10	356
Dianne Lemmon United States	7	308 1.4×	92 0.9×	121 1.8×	87 1.5×	15 0.3×	9	429
Ferhunde Dizdaroğlu Türkiye	11	54 0.3×	64 0.6×	50 0.7×	18 0.3×	39 0.8×	18	309
William Chang United Kingdom	7	173 0.8×	32 0.3×	54 0.8×	22 0.4×	67 1.4×	12	381

Countries citing papers authored by Itsuhiro Takizawa

Since Specialization

Citations

This map shows the geographic impact of Itsuhiro Takizawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Itsuhiro Takizawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Itsuhiro Takizawa more than expected).

Fields of papers citing papers by Itsuhiro Takizawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Itsuhiro Takizawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Itsuhiro Takizawa. The network helps show where Itsuhiro Takizawa may publish in the future.

Co-authorship network of co-authors of Itsuhiro Takizawa

This figure shows the co-authorship network connecting the top 25 collaborators of Itsuhiro Takizawa. A scholar is included among the top collaborators of Itsuhiro Takizawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Itsuhiro Takizawa. Itsuhiro Takizawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Takizawa, Itsuhiro, Takashi Kasahara, Ryo Maruyama, et al.. (2020). Intraoperative intraocular pressure changes during robot-assisted radical prostatectomy: associations with perioperative and clinicopathological factors. BMC Urology. 20(1). 26–26. 4 indexed citations

Tasaki, Masayuki, Takashi Kasahara, Noboru Hara, et al.. (2019). Low-Dose-Rate and High-Dose-Rate Brachytherapy for Localized Prostate Cancer in ABO-Incompatible Renal Transplant Recipients. Transplantation Proceedings. 51(3). 774–778. 5 indexed citations

Nishiyama, Tsutomu, et al.. (2017). A carbon 21 steroidal metabolite from progestin, 20β‐hydroxy‐5α‐dihydroprogesterone, stimulates the androgen receptor in prostate cancer cells. The Prostate. 78(3). 222–232. 4 indexed citations

Nishiyama, Tsutomu, Itsuhiro Takizawa, Yoshimichi Miyashiro, et al.. (2016). Dihydrotestosterone synthesis pathways from inactive androgen 5α-androstane-3β,17β-diol in prostate cancer cells: Inhibition of intratumoural 3β-hydroxysteroid dehydrogenase activities by abiraterone. Scientific Reports. 6(1). 32198–32198. 6 indexed citations

Matsubara, Nobuaki, Itsuhiro Takizawa, Tsutomu Nishiyama, et al.. (2015). A multicenter retrospective analysis of sequential treatment of abiraterone acetate followed by docetaxel in Japanese patients with metastatic castration-resistant prostate cancer. Japanese Journal of Clinical Oncology. 45(8). 774–779. 8 indexed citations

Nishiyama, Tsutomu, Takashi Kawasaki, Yoshimichi Miyashiro, et al.. (2013). Androgen deprivation promotes intratumoral synthesis of dihydrotestosterone from androgen metabolites in prostate cancer. Scientific Reports. 3(1). 1528–1528. 61 indexed citations

Hara, Noboru, et al.. (2012). Deficiency in androgens and upregulation of insulin-like growth factor-1 are involved in high bone turnover in men receiving androgen deprivation therapy for prostate cancer. Growth Hormone & IGF Research. 22(3-4). 122–128. 7 indexed citations

Hara, Noboru, Hiroshi Koike, Makoto Kawaguchi, et al.. (2012). Prediction of pathological and oncological outcomes based on extended prostate biopsy results in patients with prostate cancer receiving radical prostatectomy: a single institution study. Diagnostic Pathology. 7(1). 68–68. 14 indexed citations

Hara, Noboru, et al.. (2011). Insulin-like growth factor-1 is associated with regulation of the luteinizing hormone production in men receiving androgen deprivation therapy with gonadotropin-releasing hormone analogues for localized prostate cancer. Urologic Oncology Seminars and Original Investigations. 30(5). 596–601. 12 indexed citations

10.

Nishiyama, Tsutomu, Takashi Kawasaki, Takashi Kasahara, et al.. (2011). External Validation of the UCSF-CAPRA (University of California, San Francisco, Cancer of the Prostate Risk Assessment) in Japanese Patients Receiving Radical Prostatectomy. Japanese Journal of Clinical Oncology. 41(11). 1259–1264. 13 indexed citations

11.

Komatsu, Shuichi, Noboru Hara, Tsutomu Nishiyama, et al.. (2011). Altered association of interleukin‐6 with sex steroids in lipid metabolism disorder in men with prostate cancer receiving androgen deprivation therapy. The Prostate. 72(11). 1207–1213. 9 indexed citations

12.

Hara, Noboru, Tsutomu Nishiyama, Itsuhiro Takizawa, et al.. (2010). Decline of the Red Blood Cell Count in Patients Receiving Androgen Deprivation Therapy for Localized Prostate Cancer: Impact of ADT on Insulin-like Growth Factor-1 and Erythropoiesis. Urology. 75(6). 1441–1445. 15 indexed citations

13.

Takizawa, Itsuhiro, et al.. (2010). Trilostane, an inhibitor of 3β-hydroxysteroid dehydrogenase, has an agonistic activity on androgen receptor in human prostate cancer cells. Cancer Letters. 297(2). 226–230. 13 indexed citations

14.

Takizawa, Itsuhiro, et al.. (2010). Serum prostate‐specific antigen levels reflect the androgen milieu in patients with localized prostate cancer receiving androgen deprivation therapy: Tumor malignant potential and androgen milieu. The Prostate. 70(13). 1395–1401. 25 indexed citations

15.

Takizawa, Itsuhiro, et al.. (2010). Adrenocorticotropic Hormone is Involved in Regulation of Androgen Synthesis in Men Receiving Androgen Deprivation Therapy for Localized Prostate Cancer. The Journal of Urology. 184(5). 1971–1976. 5 indexed citations

16.

Hara, Noboru, et al.. (2009). Bone metabolic disorder in patients with prostate cancer receiving androgen deprivation therapy (ADT): impact of ADT on the growth hormone/insulin‐like growth factor‐1/parathyroid hormone axis. The Prostate. 70(2). 155–161. 11 indexed citations

17.

Takizawa, Itsuhiro, et al.. (2009). Oncological results, functional outcomes and health-related quality-of-life in men who received a radical prostatectomy or external beam radiation therapy for localized prostate cancer: a study on long-term patient outcome with risk stratification. Asian Journal of Andrology. 11(3). 283–290. 16 indexed citations

18.

Takizawa, Itsuhiro, Toshihiro Saito, Yasuo Kitamura, et al.. (2008). Primary solitary fibrous tumor (SFT) in the retroperitoneum. Urologic Oncology Seminars and Original Investigations. 26(3). 254–259. 41 indexed citations

19.

Takizawa, Itsuhiro, H Morishita, Shingo Matsuki, et al.. (2006). Primary gastrointestinal stromal tumor in the retroperitoneum. International Journal of Urology. 13(9). 1245–1248. 9 indexed citations

20.

Nishinarita, Susumu, et al.. (1981). Suppressor T cell dysfunction and depressed immunoglobulin production by B cells in vitro in patients with SLE.. PubMed. 8(1). 19–30. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact